Vice President, Global Respiratory Products Leader (MD or PhD)

*** The addition of a cover letter with a high level overview of your direct expertise in leading late stage clinical trials in asthma and/or COPD would be greatly appreciated *** The Role: Generate:Biomedicines is seeking an experienced and strategic cross-functional team leader accountable for designing and delivering our late-stage respiratory programs, including asthma and COPD. Reporting  directly to the Chief Medical Officer, this is a senior level business leader who will recruit and develop a team of physicians and scientists with accountability for the global clinical trials, collaborating with PV to ensure rigorous safety oversight, data integrity, and strategic alignment. The ideal candidate is an MD with significant industry experience in respiratory medicine and a track record of driving executional excellence in pivotal trials. Here's how you will contribute: Leads a high performing Respiratory Product Strategy Team (RPST) comprised of cross-functional leaders accountable for setting the strategy for the late stage respiratory programs Direct management and development of medical monitors and clinical scientists Develops high quality, ambitious development plans for asthma and COPD programs, aligned with late-stage and corporate objectives and compliant with all relevant regulations Recruits, mentors and manages late-state clinicians and scientists Collaborates with Head of Safety and PV to define risk-benefit profiles Collaborates with Clinical operations and CRO to deliver study to timelines and budget Oversees protocol development and clinical/scientific content for regulatory submissions and interactions Provides medical leadership and awareness of evolving external landscape for late-stage clinical trials in respiratory diseases (asthma, COPD) Drives development and refinement of Target Product Profiles (TPPs), Target Product Claims,and clinical development strategies Oversee protocol development, study design, medical review of data, and safety monitoring Serve as the primary medical contact for clinical sites, investigators, and regulatory bodies Guide interactions with external stakeholders including KOLs, advisory boards, and CROs Represent Generate externally at scientific, medical, and regulatory meetings Leadership Responsibilities Hold teams to high standards for technical and collaborative performance Build and develop a diverse, high-performing, and inclusive team culture Promote enterprise thinking and cross-functional alignment with strategic goals Communicate with clarity, courage, and empathy across all levels of the organization Foster resilience, adaptability, and informed risk-taking in pursuit of innovation The Ideal Candidate will have: MD or PhD required, board certification in Pulmonology or Allergy and Immunology Medicine preferred 10+ years of clinical development experience in the biopharma industry Deep expertise in respiratory diseases (asthma, COPD) and late-stage clinical trials Demonstrated success in leading pivotal global studies and regulatory interactions Strong analytical, communication, and cross-functional leadership skills Proven ability to influence internal and external stakeholders, including investigators and health authorities Education: MD or PhD required; additional scientific training (e.g., fellowship, MPH) a plus Nice to Have (Optional): Previous work in both large pharma and biotech settings Knowledge of global regulatory requirements (e.g., FDA, EMA) Recent successful BLA submission preferred Location: Somerville, MA / Andover, MA; remote (U.S.) optional with travel to HQ based on business needs. Why Join Us This is a unique opportunity to shape the future of respiratory medicine at a company pioneering Generative Biology™. You’ll be empowered to lead transformative trials in a collaborative, mission-driven environment, surrounded by relentless problem solvers who are reimagining what’s possible in drug discovery and development.   About Generate:Biomedicines We are a clinical-stage generative biology company pioneering the AI revolution in drug design and development. We are advancing a new approach to drug creation—one grounded in the ability to design proteins with defined biological intent. By integrating machine learning with large-scale experimentation, this approach aims to reduce the uncertainty, time, and cost associated with developing protein-based medicines. Founded in 2018, we are advancing a growing pipeline of clinical and preclinical programs across multiple disease areas and protein modalities. By unifying computational design and clinical development within a single operating model, we translate this approach into clinical-stage programs and are leading a shift from traditional drug discovery toward systematic drug generation. At Generate:Biomedicines, we collaborate across disciplines in new ways to invent and innovate. We bring diverse p